As the Gates Institute scientific writer, Drew’s role is to bridge laboratory data to clinical research through developing investigational product documents for clinical trial use. This is accomplished through collaboration with bench scientists and clinical researchers to develop insightful and robust studies.
He earned an undergraduate degree in biochemistry from Calvin University and a Ph.D. in biochemistry from Texas A&M University. For his dissertation, he studied the impact of protein chaperones on protein aggregate formation and disassembly using single particle fluorescence.
“I love communicating science to different audiences and using data to drive product development," Drew says. "Combining these passions with accelerating life-changing cell and gene therapies is a dream come true.”